Chung-Han Lee, MD, PhD

Chung-Han Lee, MD, PhD, Memorial Sloan Kettering Cancer Center

Articles by Chung-Han Lee, MD, PhD

Drs. Lee, McKay on KEYNOTE-B61 for Non-Clear Cell RCC

Chung-Han Lee, MD, PhDASCO 2023 | August 23, 2023

Drs. Lee and McKay discuss the latest data on KEYNOTE-B61 for first-line lenvatinib plus pembrolizumab for nccRCC.